Information  X 
Enter a valid email address
  Print          More announcements

Monday 19 July, 2021

Citigroup Global Mkt

Form 38.5(a) (EPT/RI)

RNS Number : 6598F
Citigroup Global Markets Limited
19 July 2021
 

 

FORM   38.5(a)

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

Citigroup Global Markets Limited

Companydealtin

UDG Healthcare plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

€0.05 ordinary shares

Date of dealing

16 July 2021

 

2.  DEALINGS  (Note   2)

 

(a)  Purchases and sales

 

Total numberofrelevantsecuritiesacquired

Highestpricepaid (Note 3)

Lowest price paid

(Note 3)

17,228

GBP 10.7400

GBP 10.7200

 

 

Total numberofsecuritiesdisposed

Highestpricereceived (Note 3)

Lowestpricereceived

(Note 3)

10,313

GBP 10.7400

GBP 10.7200

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 4)

Numberofrelevantsecurities

(Note 5)

Priceperunit

(Note 3) GBP

TRS

Increasing Short Position

63

10.7400

TRS

Increasing Short Position

4,432

10.7300

TRS

Increasing Short Position

992

10.7250

TRS

Increasing Short Position

1,113

10.7200

TRS

Reducing Long Position

315

 

10.7200

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varyingetc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, Europeanetc.

Expiry date

Option money paid/received perunit (Note 3)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 3)

 

 

 

 

 

3.   OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

Dateofdisclosure

19 July 2021

Contactname

Damian Flanagan

Telephone number

00 44 (0) 2890409676

Name of offeree/offeror with which connected

Nenelite Limited -  a company controlled by Clayton, Dubilier & Rice, LLC

Nature of connection (Note 6)

Financial Advisor

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEDKCBQFBKKOOD

a d v e r t i s e m e n t